WeRead Powered by ReaderPub
Immunity in infective diseases cover

Immunity in infective diseases

Chapter 25: INDEX.
Open in WeRead

About This Book

Systematic account of biological defenses against infection that emphasizes the role of cellular phagocytosis alongside soluble serum factors. It synthesizes experimental results, comparative pathology, and theoretical argument to explain how organisms resist or succumb to microbes, discusses mechanisms of acquired resistance and vaccination, and evaluates rival explanations. Practical consequences for preventing and treating contagious diseases are explored, and a concise historical survey at the end retraces key experiments and controversies that shaped contemporary concepts of immunity.

INDEX.

  • Abrin, 344, 345, 346, 401
  • Abrin intoxication, action of body fluids on, 365, 420;
    • leucocytic reaction against, 393, 401
  • Absorption. See Resorption
  • Acari, mechanical action of, 3
  • Acclimatisation. See Adaptation
  • Acid reaction inside phagocytes, 83, 182
  • Acid, secretion of, in osmosis, 37, 566
  • Acidophile microbian flora of stomach, 418
  • Actinians, digestion in, 53, 82, 85
  • Actinodiastase, 57, 197
  • Actinophrys, 14, 18
  • Adaptation. See also Immunity
  • Adaptation to toxic substances, 21–27, 30, 342, 390;
    • to saline solutions, 23, 30, 515;
    • to physical conditions, 26, 30–31;
    • of plasmodia to arsenious acid, 31;
    • of pancreatic secretion to kind of food, 64, 65;
    • of phagocytes to destroy micro-organisms, 281, 558, 566;
    • of animals to spinal concussion, etc., 564;
    • of cells, 513
  • Addiment (syn. Complement), 95
  • Agglutination in natural immunity, 202, 206;
    • and phagocytosis, 202, 242, 245;
    • in the diagnosis of typhoid, 256, 257, 261, 439;
    • its mechanism, 257;
    • of red blood corpuscles by serums, 258;
    • of red blood corpuscles by ricin, 360;
    • does not prevent growth of micro-organisms, 262
  • Agglutinative power, transmission by heredity or suckling, 450;
    • not developed parallel with bactericidal power, 483
  • Agglutinins in immunity, 242, 245, 256–265, 295, 542, 559;
    • characters of, 255, 559;
    • origin of, in immunised animal, 263–265, 294;
    • difference between fixatives and, 255, 265, 559;
    • not the same as protective substances, 268, 269, 294
  • Albuminoid substances, resorption of, 106–127
  • Alexins. See also Cytases
  • Alexins, 87–95, 96, 98, 184, 193, 255, 528, 533, 535, 539
  • Alimentary canal. See Intestine
  • Alizarin sulpho-acid, 13, 83, 183
  • Alligator, 77, 143, 332, 401
  • Amboceptors (syn. fixatives), 91, 93, 297, 557
  • Ammocoetes, 77, 78
  • Amoeba, 14, 18, 23, 547, 549
  • Amoebo-diastase, 16, 197, 549
  • Amoeboid cells. See Leucocytes and Phagocytes
  • Amphibia. See Frog, Axolotl
  • Amylase, 95;
    • in the urine, 65
  • Androctonus. See Scorpion
  • Anopheles and malaria, 129
  • Antagonism between certain bacteria, 323
  • Anthrax, 11, 20, 21, 25, 41, 46, 180;
    • immunity of dog against, 149–151, 242;
    • acquired immunity of Scolopendra against, 209;
    • natural immunity of white rat against, 526;
    • protective serums against, 20, 276, 309–311;
    • phagolysis in acquired immunity against, 280;
    • immunisation against, by means of other bacteria, 323;
    • infection by inhalation, 412;
    • by ingestion, 423;
    • immunity against, transmitted to offspring, 445, 447;
    • vaccinations against, 208, 241, 468–471;
    • method, 470;
    • statistics, 471;
    • vaccination against, by heated anthrax blood, 507;
    • vaccines against, 208, 470, 509;
    • phagocytosis in, 521, 523
  • Anthrax bacillus, action on rabies, 150;
    • bactericidal action of blood serums on, 20, 146, 150, 151, 156, 157, 240;
    • increasing the virulence of, 150;
    • attenuation of, 208, 288;
    • eosinophile transformation in, 198;
    • protective thickening of bacterial membrane in, 242;
    • agglutination of, 203, 242, 260, 264;
    • natural immunity against, 132–140, 143, 147, 149–159, 511, 512;
    • acquired immunity against, 239–242, 276, 277;
    • antagonism between, and certain bacteria, 323;
    • fate of, in Algerian sheep, 512;
    • destruction of, by defibrinated blood, 525
  • Anthrax, symptomatic: immunity against bacilli of, 171;
    • heredity of immunity against, 452;
    • vaccinations against, 471–473;
    • phagocytosis in, 523
  • Antiabrin, 401
  • Anti-arsenic serum, 390
  • Anticytases, 112
  • Anticytase serum, 115, 371
  • Anticytotoxins, 110, 118, 122, 127, 360
  • Antidiastase, 109
  • Antidiastatic serums, 361
  • Anti-enzymes, 109
  • Antifixative, 112
  • Antihaemolysins, 111
  • Antihaemotoxins, 111, 119, 122
  • Anti-infective. See Protective
  • Antileucocidin, 359
  • Antineurotoxin, 116
  • Antirennet, 109
  • Antiricin, 360
  • Antisepsis, Nature replaces by asepsis, 432
  • Antiseptics. See also Toxins and Adaptation
  • Antiseptics and foods, 26
  • Antiseptic action of the gastric juice, 417
  • Antispermofixative, 124
  • Antispermotoxins, 116, 122–126
  • Antistreptococcic serum, 243–245
  • Antitetanin, nervous origin of, 390
  • Antitoxic. See also Protective
  • Antitoxic unit of Ehrlich, 373, 496;
    • action of non-specific and normal serums and of broth, 365;
    • function of the saliva, 417;
    • function of pepsin and other digestive ferments, 419, 424;
    • action of intestinal flora, 427;
    • property of the body fluids, 531 (see Body fluids, Serums);
    • power of the blood of new-born children, 445
  • Antitoxins, natural, in normal blood, 111, 204, 444;
    • rarity in body fluids in natural immunity, 204, 532, 533;
    • development of, during immunisation, 354;
    • properties of, 354;
    • present in various fluids of immunised animal, 355, 531;
    • mode of action of, on toxins, 356–362, 371;
    • conditions acting in mixtures of, with toxins, 362;
    • immunity against toxins not in direct constant ratio to amount of, 367–376;
    • effect of using serum from same species, 379;
    • hypothesis as to nature and origin of, 377–402, 562;
    • probable part played by phagocytes in production of, 400–402;
    • rapid regeneration of, after bleeding, 379;
    • augmentation in production of, by pilocarpin, 380;
    • transmission of, by milk to offspring, 449;
    • analogy of, with fixatives, 561;
    • hypersecretion of, 563
  • Antivenomous property of blood of scorpion, 328;
  • Aqueous humour, bactericidal action of, 184, 192;
    • in immunised animals contains no fixative, 217, 222;
    • in immunised animals contains antitoxin, 355
  • Arsenic; adaptation to, 31, 343, 390;
    • protective serum against, 390;
    • leucocytic reaction against, 396–399;
    • as a remedy against microbial disease, 513
  • Arsenic acid, action of, on anthrax bacillus, 25
  • Arsenious acid, adaptation of plasmodia to, 31
  • Arthropoda. See Clothes-moth, Crayfish, Crustacea, Daphnia, Scolopendra, Scorpion, Spider, Tick
  • Arthrospores of Hueppe, 254
  • Ascaris, poor microbian flora in intestine of, 421;
    • phagocytic organs of, 547
  • Asepsis is Nature’s method, 432
  • Aspergillosis, 2, 4.
    • See also Mycoses
  • Atrophic diseases, probably due to a parasite, 3
  • Atropin, reaction of rabbit and guinea-pig to, 395, 396
  • Attenuation. See also Vaccination, Vaccines
  • Attenuation of micro-organisms and viruses, discovery and application of, 208, 247, 288, 508;
    • of micro-organisms by the fluids of immunised animals, 286–289;
    • of toxins, 344
  • Autodigestion in yeast, 197
  • Autospermotoxins, 101
  • Autotoxins, 104
  • Axolotl, susceptible to tetanus toxin, 330
  • Bacilli, anaerobic, natural immunity against, 169, 170
  • Bacillus aërogenes, agglutination in, 264
  • Bacillus chauraei. See Anthrax symptomatic
  • Bacillus coli attacks potato, 35;
    • vaccination against, 267;
    • transformation of, into granules, 198;
    • modified growth on certain serums, 259
  • Bacillus of Doederlein, 429;
    • of Kiel water, 408
  • Bacillus pyocyaneus, 42, 180, 254, 528;
    • acquired immunity against, 210, 232–236, 301;
    • Pfeiffer’s phenomenon in, 234, 307;
    • special forms of growth in serums from vaccinated animals, 256;
    • agglutination of, 261, 307;
    • susceptibility to the toxins of, 290, 351;
    • action of specific serum on, 307, 358;
    • antagonistic to anthrax bacillus, 323;
    • immunisation against toxin of, 351;
    • a leucocidin from, 359;
    • action of liver on toxin of, 427;
    • heredity of immunity against toxin of, 446
  • Bacillus ranicida, 140
  • Bacteria. See Micro-organisms
  • Bactericidal action of serum, influence of alkalinity or acidity on, 196;
    • function of the tears, 408
  • Bactericidal property. See also Body fluids, Humoral theory, Serums
  • Bactericidal property: in blood and other fluids, 20, 146, 150, 151, 156, 157, 184–193, 211, 226, 233, 238, 240, 241, 243, 244, 512, 525–531, 542, 554;
    • of body fluids, theory of osmotic pressure, 193, 213;
    • of extracts of glands and exudations, 195;
    • of the saliva, 415;
    • absence of, from the intestinal ferments, 424, 567;
    • of serums, Wright’s method of testing, 483;
    • does not develop parallel with agglutinative, 483;
    • and immunity, absence of parallelism, 554
  • Bactericidal substance (alexin, complement, cytase): in blood and other fluids, 184–193, 534;
    • source of, in body fluids, 185–193;
    • theory of leucocytic secretions, 187–191;
    • presence in body fluids due to phagolysis, 191;
    • is of phagocytic origin, 185, 192;
    • in body fluids, microphages source of, 187;
    • not resistant to heat, 268;
    • and so distinguished from protective substance, 268;
    • Pfeiffer’s theory of, 534
  • Bacteriolysis. See Micro-organisms, destruction of
  • Bacteriolysis, analogy between haemolysis and, 537
  • Bat, immunity against tetanus of hibernating, 339
  • Baumès-Colles’ law in syphilis, 436
  • Behring’s “normal serum,” 496
  • Bile, function of, 60;
    • salts protective against snake venom, 388;
    • protective function of, 424
  • Bipinnaria, 70, 518
  • Blastomycetes. See also Yeast-cells
  • Blastomycetes, resistance of Daphnia to, 131, 404, 520;
    • fate of, in refractory organism, 172;
    • acidophile, 418
  • Blood, pepsin in the, 66, 563;
    • precipitins in the, 68, 106, 107, 568;
    • fate of effusions of, 73;
    • bactericidal power of, 184 (see also Bactericidal, Serums);
    • natural antitoxins in normal, 111, 204, 444;
    • stimulant (protective) action of human, 271, 318;
    • immunity conferred by maternal, 447;
    • recognition of, in medico-legal research, 107, 568;
    • from convalescents, protective power of, 437, 441, 443;
    • agglutination of (see Agglutination)
  • Blood corpuscles, resorption of red, 47, 50, 56, 57, 70, 72, 79–100, 537 (see also Haemolysis);
    • fixation of cytase by red, 194;
    • agglutination of red, by serums, 258;
    • agglutination of red, by ricin, 360
  • Body fluids. See also Bactericidal, Blood, Humoral theory, Serums
  • Body fluids, natural immunity and the composition of, 128–131, 146;
    • in natural immunity, absence of antitoxic property in, 204;
    • bactericidal power of, 184–193, 512, 525–531, 542 (see also Body fluids, Serums);
    • antitoxic power of the, 204, 531, 533, 543;
    • protective properties of, 266–280
  • Boophilus bovis, 247
  • Bordet’s sensibilising substance, 91, 199, 298, 535, 537, 557
  • Botulism, protective action of fats against toxin of, 387;
    • action of digestive diastases on toxin of, 420
  • Bouchard’s theory of acquired immunity, 232, 286;
    • of attenuating power of serums, 286–289
  • Bouillon de panse, 473
  • Bovidae, acquired immunity of, against Texas fever, 247, 279;
    • protection of, against tetanus, 494;
    • vaccination of, against rinderpest, 425, 466–468;
    • against rabies, 466;
    • against anthrax, 470;
    • against symptomatic anthrax, 471;
    • against pleuropneumonia, 477–479;
    • ancient methods against pleuropneumonia in, 506
  • Broth as a protective fluid, 320, 321, 365
  • Buccal cavity, microbial products in the protection of the, 416;
    • flora of, 414
  • Buchner’s theory of immunity, 512, 527
  • Calf lymph vaccine, method of preparation, 456
  • Carassius. See Goldfish
  • Carmine, fixation of tetanus toxin by, 388, 394
  • Cattle. See Bovidae
  • Cattle plague. See Rinderpest
  • Cayman. See Alligator
  • Cellular or histogenic immunity, 335, 336, 340, 563–565
  • Cellulosase, 86
  • Cerebral substance, action of emulsions of, on toxins, 386
  • Cerebral tetanus, 383, 391
  • Chemiotaxis. See also Hyperleucocytosis, Susceptibility
  • Chemiotaxis in Infusoria, 19;
    • in plasmodia of the Myxomycetes, 30;
    • of duodenal mucous membrane, 64;
    • of phagocytes, 79, 108, 133, 167, 177, 280;
    • of leucocytes for rennet, &c., 119;
    • positive, in segmentation-cells of frog embryo, 565
  • Cholera antibody (fixative), 253, 267, 292
  • Cholera, Asiatic, protective power of blood of convalescents from, 441;
    • vaccinations against, 480–481
  • Cholera peritonitis, heredity of immunity against, 447, 448;
    • immunity of guinea-pig against, 533
  • Cholera toxin, alligator resistant to, 333;
    • immunisation against, 350;
    • action of normal serum of goat on, 365
  • Cholera vibrio. See also Pfeiffer’s phenomenon, Vibrios
  • Cholera vibrio, adaptation of, to bactericidal substance, 23;
    • susceptibility of larva of Rhinoceros beetle to, 40, 133;
    • immunity of frog against, 142;
    • of guinea-pig against, 163, 533;
    • extracellular destruction of, 165, 212 (see also Pfeiffer’s phenomenon);
    • eosinophile transformation in, 198;
    • arthrospores of, 254;
    • agglutination of, 261, 264;
    • protective action of serums against, 268, 271, 318;
    • of human blood against, 271, 318;
    • immunity to, is not insusceptibility to its toxin, 290;
    • origin of protective property against, 291;
    • protective action of various fluids against, 320;
    • antagonism between certain bacteria and, 324;
    • in stomach, 419, 567;
    • susceptible to acids in vitro, 419;
    • in intestine, 423, 567;
    • serum from animals immunised against, 532
  • Cholesterin. See also Fats
  • Cholesterin, fixation of toxins by, 387;
    • fixation of saponin by, 389
  • Chytridium, 12
  • Cicatrisation of plants, 34
  • Clasmatocytes, 78
  • Clavelée (la). See Sheep-pox
  • Clavelisation against Sheep-pox, 460
  • Clothes-moths, micro-organisms absent from digestive canal of larvae of certain, 420
  • Coccobacillus prodigiosus. See under Micrococcus
  • Cockchafer larva, 70, 326
  • Complement of Ehrlich, 88, 91, 193, 251, 297
  • Complementoids of Ehrlich, 115
  • Concussion, spinal, adaptation to, 564
  • Conjunctiva, elimination of micro-organisms by the, 408;
    • absorption of toxins by the, 409
  • Copula of P. Müller, 91
  • Cornea, protective resistance by the, 409
  • Crayfish, susceptible to certain toxins, 345;
    • blood of, antitoxic against scorpion venom, 366;
    • poor intestinal flora of, 421
  • Crickets and micro-organisms, 41, 133;
    • natural immunity against toxins in, 329
  • Crustacea. See Crayfish, Daphnia
  • Crustacea, protective function of integument of, 404
  • Cyprinus. See Goldfish
  • Cytase of Laurent, 86
  • Cytases (syn. alexins, complements), 93, 98, 123;
    • elaborated by phagocytes, 197, 252, 539, 549–556;
    • thrown out into plasmas during phagolysis, 95, 99, 102, 197, 252, 551–554;
    • bactericidal power of, 183, 184, 191, 193–198, 217 (see also Bactericidal, Body fluids, Serums);
    • unity or plurality of, in same serum, 193, 197;
    • absorption of, 194, 200;
    • two kinds of, macrocytase and microcytase, 195, 296, 549;
    • characters of the, 197, 549;
    • enzymes other than, in phagocytes, 197;
    • in the immunised organism, 250–255, 296, 317, 554;
    • presence or absence of, how determined, 253;
    • Ehrlich’s and author’s views on, contrasted, 297;
    • compared with fixatives, 555
  • Cytotoxins, 105 (note), 110, 116
  • Daphnia, resistance of, to Blastomycetes, 131, 404, 520
  • Darwin on the extinction of the elephant, 8
  • Dermis, arrest of micro-organisms in the, 406
  • Desmon (of London), 91
  • Diastases. See Digestive ferments, Ferments
  • Digestion in the higher animals, 49, 59–65;
    • psychical and nervous elements in, 62, 566;
    • extracellular, by secreted juices, 49, 58, 62;
    • the liver of the Mollusca as second organ of, 59;
    • in the tissues, 67;
    • and resorption closely related, 69, 85;
    • by macrophagic organs, 85, 150
  • Digestion, intracellular. See also Phagocytes, Phagocytosis, Resorption
  • Digestion, intracellular, 48, 85, 517, 518, 520;
    • in the Protozoa, 13, 30, 49;
    • in Planarians, 49, 71, 82;
    • in Actinians, 53, 82, 85;
    • in Sponges, 69, 517;
    • transition from, to digestion by secreted juices, 49, 58
  • Digestive ferments, antitoxic function of, 424;
    • action of, on toxin of botulism, 420
  • Diphtheria, 7, 41, 132, 204;
    • antitoxic power of blood of convalescents from, 443;
    • antitoxic power against, in blood of healthy persons, 444;
    • and in blood of new-born children, 445;
    • heredity of immunity against, 445, 447, 448;
    • influence of anticytase serum on, 371;
    • vaccinations against, 495–503;
    • serum against, 495;
    • standardisation and testing of this serum, 496–498;
    • its protective and antitoxic powers do not develop in equal ratio, 497;
    • its prophylactic use, 498–503;
    • accidents during treatment, 499, 502;
    • statistics, 500–503
  • Diphtheria toxin, increased susceptibility of immunised guinea-pig to, 290;
    • natural immunity of rat and mouse against, 204, 339;
    • natural immunity of frog against, 330;
    • immunisation against, 344, 347, 349, 353;
    • attenuation of, 344;
    • preventive action of nucleohiston on, 365;
    • action of, on brain of laboratory animals, 386;
    • sets up local lesions in the conjunctiva, 409;
    • pepsin destroys, 419
  • Diplococcus pneumoniae. See Pneumococcus
  • Diseases, fear of, and pessimism, 1, 569;
    • atrophic, probably due to a parasite, 3;
    • mechanical element as etiological factor, 3;
    • toxic element as etiological factor, 4;
    • developed on the earth at a very early epoch, 8;
    • and extinction of species, 8;
    • infective, in multicellular plants, 29–39;
    • set up by Fungi. See Fungi
  • Dog, immunity of, against anthrax, 149–151, 242;
    • action of anthrax bacillus on rabid, 150;
    • immunity of, against streptococci, 167;
    • naturally refractory against a staphylococcus, 266;
    • bactericidal action of blood of, on anthrax bacillus, 150, 151, 156;
    • digestion of gelatine by leucocytes of, 108;
    • enterokynase in lymphoid organs of, 61;
    • digestive fluids of, 62–65;
    • disinfecting power of small intestine of, 422;
    • phagocytosis in, 149, 151;
    • haematozoon in, 279
  • Domestic animals, immunisation of, against disease. See Bovidae, Dog, Goat, Horse, Pig, Sheep, Swine, Vaccines, Vaccinations
  • Dourine, 2, 247
  • Drepanidium, 515
  • Drugs, absorption of, by leucocytes, 400
  • Duodenum, chemiotaxis of mucous membrane of, 64
  • “Dust” cells, 75, 411–414
  • Eel’s serum. See also Ichthyotoxin
  • Eel’s serum, toxic action of, 20, 111, 563;
    • and precipitins, 68, 106
  • Effusions of blood, fate of, 73
  • Ehrlich’s neutral red reaction, 13, 83, 181;
    • classification of leucocytes, 74, 76–78;
    • theory of side-chains or receptors, 120, 381–384, 538, 557, 562–563;
    • compared with theory of phagocytes, 296–299, 538, 558;
    • “immunising unit,” 373, 496
  • Elephant, extinction of, 8
  • Elimination of micro-organisms from the body, 43, 46;
    • by the epidermis, 406;
    • by the conjunctiva, 408;
    • by the nasal mucosa, 410
  • Emys. See Turtle
  • Endo-enzymes, 197
  • Endotrypsin of yeast, 197
  • Enterokynase, 59, 98
  • Enzymes. See Ferments
  • Eosinophile leucocytes, secretion by, in bacteriolysis, 187, 542
  • Eosinophile staining reaction, 198
  • Epidermis, exfoliation of the, 406
  • Ernst’s bacillus, immunity of frog against, 140
  • Erysipelas. See Swine erysipelas
  • Erysipelas, immunity in, 434
  • Erysipelas streptococcus, protective action of, against anthrax, 323;
    • its use in malignant tumours, 434
  • Excretion. See also Elimination
  • Excretion in relation to micro-organisms, 43, 432;
    • of pepsin in the urine, 65;
    • of pepsin in the blood, 66, 563
  • Exfoliation of the epidermis, 406
  • Exudations, bactericidal power of, 185, 193, 195
  • Farcy, slow evolution of, 406
  • Fats, protective action of, against toxins, 387
  • Ferments. See also Intestinal, Digestive, Fibrin-ferment, Gastric juice, Saliva, Trypsin
  • Ferments, Pasteur on the organised nature of, 2;
    • soluble (diastases or enzymes), in digestion, 49, 55, 57, 108, 109, 197;
    • antitoxic function of digestive, 424;
    • phagocytic, 197, 549–559;
    • hypersecretion of, 563
  • Fibrin ferment (plasmase), 95, 197, 550
  • Fishes. See Goldfish
  • Fishes, phagocytosis in, 135
  • Fixatives (immunising body, or amboceptor, or sensibilising substance), 88, 92–95, 97, 98, 103–105, 199–202, 296;
    • synonyms of, 91;
    • analogy of, with enterokynase, 98;
    • presence of, in plasmas, 103, 112–114, 217;
    • in protective serums, 269, 438;
    • in mesenteric glands, 98;
    • in spermotoxins, 101;
    • origin of, 103, 294, 537, 556–559;
    • specificity of, 88, 105, 216, 251, 253, 296;
    • rarity of, in normal fluids, 199–201, 250;
    • method of determining whether present in a serum, 199;
    • absent from aqueous humour of immunised animals, 217, 222, 251;
    • in the immunised organism, 250–255;
    • properties of, 251, 253, 255, 554;
    • differ from agglutinative substances, 255, 265, 559;
    • relation of, to phagocytosis, 291, 295;
    • part played by, in Pfeiffer’s phenomenon, 251, 295;
    • and protective substances closely connected, 269, 294, 295, 561;
    • compared with cytases, 555;
    • mechanism of action of, 557
  • Food substances, absorption of, by other channel than alimentary canal, 67
  • Foods and antiseptics, 26
  • Foreign bodies, fate of, in organism, 46, 52, 55, 56, 517
  • Formed elements, resorption of the, 47, 67–105
  • Fowl, immunity of, against anthrax, 144, 159;
    • phagocytosis in, 144, 282;
    • bactericidal action of plasma of, on anthrax, 146;
    • blood serum of, and tetanus, 204;
    • immunity of, against tetanus, 204;
    • natural immunity of, against tetanus toxin, 335;
    • influence of removal of parts of brain and cord on tetanus in, 384
  • Fowl cholera, infection of laboratory animals with, 181;
    • vaccine against, 208;
    • phagocytosis in, 282;
    • action of exudations of fowls vaccinated against, 288;
    • acquired immunity against, 288, 508;
    • failure of bacillus of, to grow in certain media, 510
  • Friedländer’s bacillus prevents infection by anthrax, 323
  • Frog, phagocytosis in, 137, 142;
    • immunity of, against anthrax, 137;
    • against Ernst’s bacillus, 140;
    • against bacillus of mouse septicaemia, 141;
    • against cholera vibrio, 142;
    • acquired immunity of, against pyocyanic disease, 210, 301;
    • natural immunity of, against tetanus toxin, 330;
    • against diphtheria toxin, 330;
    • immunisation of, against abrin, 345;
    • absorption of tetanus toxin by brain of, 386
  • Frog embryo, positive chemiotaxis in segmentation-cells of, 565
  • Fungi, diseases set up by, 2, 4, 18, 32, 131, 135, 404
    • (see also Aspergillosis, Mycoses)
  • Galactose. See Milk-sugar
  • Gamaleia’s vibrio. See Vibrio metchnikovi
  • Gastric juice, antiseptic action of, 417;
    • psychic influence on, 63, 566.
    • See Pepsin
  • Gelatine, resorption of, 107
  • Gentilly bacillus. See Pneumo-enteritis
  • Gerbil, tubercle in, 22, 183
  • Goat, action of normal serum of, on cholera toxin, 365;
    • vaccination of, against rabies, 466;
    • acquired immunity in, 563
  • Goldfish, 72, 135
  • Goose septicaemia. See Spirochaete anserina
  • “Greek method” of variolisation against small-pox, 507
  • Gruber’s theory of immunity, 256, 262
  • Guinea-pig, immunity of, against spirilla, 160, 162;
    • against vibrios, 163, 211–227, 275, 287, 531, 533;
    • against streptococci, 165;
    • against tetanus bacillus, 169;
    • against symptomatic anthrax, 171;
    • against Trypanosomata, 173;
    • acquired immunity against spirilla of recurrent fever, 227–230;
    • against typhoid, 191, 230;
    • against Bacillus pyocyaneus, 234–236;
    • against anthrax, 276, 277;
    • phagocytosis in, 162, 163, 166, 170, 223;
    • hypersusceptibility of immunised, to diphtheria toxin, 290;
    • protective power of serum of immunised, 293;
    • effect of removal of spleen of, 293;
    • antivenomous action of serum of, 338;
    • immunisation of, against cholera toxin, 351;
    • increasing natural susceptibility of, to toxins, 369, 370;
    • reaction of, to atropin, 396
  • Haematopoietic organs. See also Lymphoid organs
  • Haematopoietic organs as source of protective substance, 292–294
  • Haematozoa. See Piroplasma, Trypanosoma
  • Haematozoon in dog closely allied to that of Texas fever, 279
  • Haemolysis. See also Blood corpuscles, resorption of
  • Haemolysis, 79–100, 111, 112, 537;
    • the two substances which act in, 88, 98, 538;
    • analogy between bacteriolysis and, 537
  • Haemomacrophages, 76, 136
  • Haptophore atomic group in a toxin, 120, 350, 384
  • Hedgehog, natural immunity of, against poisons and venoms, 337
  • Helix pomatia, 70, 134
  • Heredity of immunity, 445–453, 513
  • Herpestes. See Mongoose
  • Hibernation, effects on resistance to toxins, 339
  • Hippocampus, 135
  • Histogenic immunity, 336
    • (see Immunity, cellular)
  • Hog cholera, resemblance of bacillus of, to that of pneumo-enteritis, 259;
    • serum of animals vaccinated against, 260;
    • agglutination in, 260;
    • protective action of serums against, 272;
    • susceptibility of vaccinated animals to the toxin, 290
  • Horse. See also Diphtheria
  • Horse, acquired immunity against cholera vibrio, 222;
    • against streptococci, 244, 245, 313;
    • local reaction to tetanus toxin in, 352;
    • immunised, with poor yield in antitoxin, 373, 375;
    • reaction of, to one unit of toxin, 378;
    • antitoxic power of serum of normal, 380;
    • phagocytosis in, 245, 313;
    • antivenomous action of serum of, 338;
    • vaccination of, against rabies, 466;
    • vaccination of, against anthrax, 470;
    • protective serum against tetanus in, 493
  • Humoral phenomena in immunity, 184, 250, 290, 437–440, 525–531, 542, 543
  • Humoral theories of immunity, 184, 525–531, 542, 543;
    • attempts to reconcile with theory of phagocytes, 539
  • Humours. See Body fluids, Serums
  • Hyperleucocytosis. See also Chemiotaxis
  • Hyperleucocytosis during immunisation, 352, 393
  • Hypersecretion, 563 (see Receptors)
  • Hypersusceptibility to toxins in immunised animals, 290, 368–374, 564
  • Hyphomycetes, diseases caused by, 2
  • Hypopyon, pus of, 96
  • Ichthyotoxin, 110, 120, 121, 122, 326, 360
    • (see also Eel’s serum)
  • Immunisation. See Immunity, acquired, artificial and temporary, Vaccination
  • Immunisation against toxins, principal methods of, 345–350;
    • by unmodified toxins, 345–346;
    • by modified toxins, 347;
    • by mixtures of toxin and antitoxin, 348;
    • by toxones and toxoids, 349;
    • phenomena produced during, 352–354
  • Immunising body of Ehrlich, 91, 251;
  • Immunity, historical sketch, 505–543;
    • summary, 544–569;
    • by attenuated micro-organisms, 2;
    • predisposition or absence of, 7;
    • against infective diseases, 9;
    • definition of, 10;
    • against micro-organisms, 10, 41, 42, 128–206, 207–324;
    • against toxins, 10, 41, 42, 325–341, 342–402;
    • not same as against micro-organisms, 290, 351;
    • in unicellular organisms, 11–28;
    • in multicellular plants, 29–39;
    • in plants, action of manures on, 36;
    • in the animal kingdom, 40–66;
    • cellular or histogenic, 335, 336, 340, 563–565;
    • active (Ehrlich), 378 = isopathic immunity (von Behring);
    • passive (Ehrlich), 378, 453 = antitoxic immunity (von Behring);
    • passive against micro-organisms, 300–324, 560;
    • isopathic (von Behring), 378;
    • antitoxic (von Behring), 378;
    • of the skin, 403–407;
    • of the mucous membranes, 407–432;
    • susceptibility in, 565 (see also Hypersusceptibility, Susceptibility);
    • channel of entrance in, 567;
    • applications of theory of, to medical practice and to the research of new organisms, 567–569
  • Immunity, natural: 10, 17, 18, 30;
    • amongst Invertebrates, 40, 131–135;
    • amongst Vertebrata, 41, 135–174;
    • against micro-organisms, 128–174, 175–206;
    • and composition of body fluids, 128–131;
    • against anaerobic bacteria, 169, 170;
    • part played by inflammation in, 176;
    • importance of microphages in, 177;
    • humoral theory of, 184;
    • agglutination in, 202, 206;
    • against toxins, 325–341
  • Immunity, acquired: 10, 19, 31;
    • against micro-organisms, 207–249, 250–299;
    • against vibrios, 211–227;
    • against pyocyanic disease, 210, 232–236, 301;
    • against spirilla of recurrent fever, 227–230;
    • against typhoid bacillus, 230;
    • against swine erysipelas, 236–239;
    • against anthrax, 239–242;
    • against streptococcus, 243–247;
    • against Trypanosomata, 247–249, 316;
    • against staphylococcus, 266
  • Immunity, rapid and temporary: against micro-organisms, 300–324;
    • conferred by specific serums, 301–317;
    • conferred by normal serums, 317–320;
    • conferred by fluids other than serums, 320–322;
    • conferred by non-specific micro-organisms, 322–324
  • Immunity, artificial, against toxins, 342–402;
    • against bacterial toxins, 343;
    • against vegetable toxins, 344, 365;
    • against snake venom, 345;
    • not in direct ratio to amount of antitoxin in body fluids, 367–376
  • Immunity acquired by natural means, 433–453;
    • acquired after recovery from infective diseases, 433–444;
    • acquired by heredity, 445–453;
    • conferred by maternal blood, 447;
    • by the yolk, 449;
    • by the milk of the mother, 449
  • Immunity, acquired: amongst Invertebrata, 209–210;
    • amongst Vertebrata, 210–249;
    • relation of Pfeiffer’s phenomenon to, 224;
    • Bouchard’s theory of, 232, 286;
    • double action of cytases and fixatives in, 250–255, 296, 554;
    • agglutinative substances in, 242, 245, 256–265, 295, 542, 559;
    • protective properties of body fluids in, 266–280;
    • phagocytosis in, 220, 223–226, 245, 280–286, 295;
    • origin of fixative properties in body fluids in, 294;
    • relation between fixatives and phagocytosis in, 291, 295;
    • humoral phenomena in, 184, 250, 290, 525–531, 542, 543;
    • bactericidal power of fluids in, 250;
    • Gruber’s theory of, 256, 262;
    • against micro-organisms, susceptibility to the specific toxin in, 289;
    • principal phenomena associated with, 295–296;
    • against micro-organisms in no ratio to protective power of blood, 372–374;
    • by suckling, mouse the only animal in which, 450, 452;
    • theory of exhaustion of nutrient medium as cause of, 510–512;
    • theory of presence of inhibitory substance, 511, 512;
    • theory of local inflammatory reaction, 512;
    • theory of adaptation of cells in, 513;
    • theory of phagocytes in, 514–525, 539–543;
    • theory of bactericidal power of body fluids, 525–531, 542, 543;
    • theory of antitoxic power of body fluids, 531;
    • theory of extracellular destruction of micro-organisms by leucocytic secretions, 187–191, 533–537, 542;
    • theory of side-chains, 120, 381–384, 538, 557, 562–563;
    • present phase of the question of, 540–543
  • Immunproteidin of Emmerich and Löw, 254
  • Infection, agents, mechanical and other, that prevent or aid, 3–5, 170–173, 426
    • (see also Diseases, Elimination, Micro-organisms)
  • Inflammation in immunity, 176, 512;
  • Influenza bacillus, cultivation of, in body fluids, 130, 554;
    • vaccination against, 277
  • Infusoria. See also Trypanosoma
  • Infusoria, 12–20, 23, 26, 326
  • Inoculation. See Immunisation, Vaccination
  • Insects, natural immunity in, 132, 326, 329;
    • acquired immunity in, 209;
    • protective lining of digestive canal of, 421
  • Insusceptibility of cells of refractory animals, 341
  • Integument of Invertebrata, protective function of, 404
  • Intermediary body, 88, 91, 296, 557
  • Intestine, protective function of the, 422;
    • microbian flora of, 420;
    • antitoxic action of this flora, 427
  • Intestinal ferments, absence of microbicidal power from, 424, 567;
    • intestinal micro-organisms, favouring and retarding functions of, 426;
    • destruction of toxins by, 427
  • Invertebrata, natural immunity in the, 40, 131–135, 326–329;
    • acquired immunity in the, 209–210, 301;
    • immunisation of, by specific serums, 301;
    • protective function of integument of, 404
  • Iodine trichloride in immunisation, 347
  • Iron, absorption of, by leucocytes, 399
  • Irritability, part played by, 18, 27 (see also Susceptibility);
    • in plants, 38
  • Isaria, resistance to infection by, 329
  • Koch’s phenomenon in tuberculosis, 437
  • Kupffer’s cells, 75
  • Leprosy, etiological factors in, 4
  • Leprosy bacillus, 75, 411
  • Leucocidin, and its neutralisation, 359
  • Leucocytes. See also Phagocytes
  • Leucocytes (amoeboid cells) in resorption, 47, 73, 175, 514, 515;
    • adaptation of, to virulent bacteria, an education, 281;
    • various categories of, 74–79;
    • soluble ferments of, 95;
    • chemiotaxis of, 119, 177;
    • theory of bactericidal secretions by, 187–191, 533–537, 539, 540, 542;
    • action of leucocidin on, 359;
    • absorption of poisons by, 393–400;
    • situations where there are no pre-existing, 551
  • Lily of the valley, acquired immunity in, 513, 515
  • Liver, serum against cytotoxin acting on, 116;
    • protective function of the, 427;
    • of Mollusca an organ of second digestion, 59
  • Lizard, resistance of, to tetanus toxin, 332
  • Lugol’s solution in immunisation, 347
  • Lupus, slow growth of, 406
  • Lymphocytes. See also Leucocytes, Phagocytes
  • Lymphocytes, 76, 78
  • Lymphoid organs. See also Haematopoietic organs, Phagocytic organs
  • Lymphoid organs, protective function of the, 428;
    • as source of sensibilising substance (fixative), 537
  • Lymphomacrophages, 76
  • Macrocytase (alexin, complement), 86, 98, 105, 112, 196, 549;
    • analogy of, with actinodiastase, 86;
    • escape of, during phagolysis, 95, 99, 102, 552;
    • presence of, in spermotoxin, 101;
    • origin of, 103;
    • active for resorption of animal cells, 196, 197, 296;
    • in extracellular solution of red corpuscles, 552
  • Macrophages, 76, 77, 79, 547;
    • the part they play in resorption, 80–100, 176;
    • staining reactions of, 77;
    • in phagocytosis, 144, 148, 154, 157, 161, 162, 164, 173, 184, 228, 245, 321, 548;
    • act more especially in resorption of animal cells, 176, 196, 548;
    • but intervene specially against human tubercle bacillus in pigeon, 148;
    • against spirilla, 162, 177, 228;
    • and against streptococci, 245;
    • not source of bactericidal substance in body fluids, 187;
    • part played by, in arsenic poisoning, 397;
    • the principal source of antitoxin, 401;
    • of skin, reaction of, against micro-organisms, 407
  • Macrophagic organs, digestive property of, 85, 150
  • Malaria, immunity against, 129, 278;
    • protective action of serum in, 278;
    • immunity acquired after, 434
  • Manures, influence on plant diseases, 36
  • Marmot, immunity of hibernating, against tetanus, 339
  • Martin’s broth (bouillon de panse), 473
  • Massowah vibrio, acquired immunity against, 221;
    • action of specific serum on, 305
  • Mastzellen, 77
  • Membranes, protective secretion of, by bacteria, 21, 242
  • Meriones shawii, 22, 183
  • Mesenteric glands, 62, 85, 98, 195
  • Mesoderm, function of amoeboid cells of, 518
  • Microbicidal. See Bactericidal
  • Micrococcus prodigiosus, 42, 45;
    • antagonistic to anthrax bacillus, 323;
    • action of vaginal mucus on, 430
  • Microcytase digests bacteria, 196, 197, 296, 550;
    • in immunity, 218;
    • escape of, during phagolysis, 218, 222, 230, 295, 554;
    • transforms vibrios into granules, 552;
    • action of, on Vibrio metchnikovi, 553
  • Micro-organisms, minuteness of certain pathogenic, 3;
    • variability in action of, 5;
    • staining reactions of, 13, 83, 181, 183, 198, 213;
    • immunity by attenuated, 2, 509;
    • pathogenic, in healthy persons, 7;
    • adaptation of, to toxic substances, 21, 25;
    • protective secretion of membranes by, 21, 242;
    • defence in plants against, 35;
    • defences of animals against, 545;
    • elimination of, from the body, 43, 46 (see also Elimination);
    • resorption of, 46, 175, 546;
    • antidiastase against enzymes of, 109;
    • natural immunity against pathogenic, 128–174, 175–206;
    • acquired immunity against pathogenic, 207–249, 250–299, 300–324;
    • anaerobic, immunity against, 169, 170;
    • pathogenic animal, 2, 173, 247–249, 277–279, 316;
    • destruction of, an act of resorption, 175, 206 (see Bacteriolysis);
    • presence of, in white corpuscles, 514;
    • adaptation of phagocytes to destroy, 558, 566;
    • mode of entry into phagocytes, 177;
    • digested by phagocytes, 181, 514–525, 536, 539–543 (see Phagocytes, Phagocytosis);
    • transformation into spherical granules, 198 (see also Pfeiffer’s phenomenon);
    • extracellular destruction of, 165, 212, 533–537, 542;
    • modified growth in serums from immunised animals, 256, 259 (see also Agglutination);
    • specific diagnosis of, by modified growth, 256, 259;
    • agglutination does not prevent growth of, 262;
    • changes which they undergo in immunised animal, 289;
    • attenuation of, 208, 286–289, 508;
    • adjuvant and retarding functions of, 170, 426;
    • antagonism between anthrax and certain, 323;
    • antagonism between cholera vibrio and certain, 324;
    • acidophile, 418;
    • exfoliation of epidermis to get rid of, 406;
    • localisation and arrest of, in the dermis, 406;
    • destruction of toxins by, 427
  • Microphages, 77, 78, 79, 148, 152, 154, 162, 164, 172, 185, 245, 548;
    • intervene specially against micro-organisms and in acute infections, 177, 196, 206, 549;
    • source of bactericidal substance in body fluids, 187, 195;
    • granular transformation of vibrios inside, 164, 165, 224
    • (see also Pfeiffer’s phenomenon)
  • Microsphaera, 18
  • Milk, absorption of, 107;
    • precipitins in the differentiation of various kinds of, 107, 568;
    • of immunised animals, antitoxin in, 356;
    • immunity conferred by mother’s, 449, 450, 452;
    • transmission of agglutinative power by, 450
  • Milk-sugar, adaptation of yeasts to, 26
  • Mithridates, method of protecting himself against poisons, 343
  • Mollusca. See also Helix, Phyllirhoë, Thetys
  • Mollusca, natural immunity in, 134;
    • liver of, an organ of second digestion, 59
  • Mongoose, immunity of, against snake venom, 339
  • Monkeys, immunised, with poor yield in antitoxin, 373;
    • immunisation of, against diphtheria toxin, 373;
    • transient acquired immunity against recurrent fever, 434
  • Monospora, parasite of Daphnia disease, 131, 404, 520
  • Morphia, adaptation to, 343
  • Mouse, infection of, by swine erysipelas, 270, 307, 476;
    • the only animal that acquires immunity by suckling, 450, 452;
    • acquired immunity of, against typhoid, 230;
    • natural immunity of, against diphtheria toxin, 204, 339
  • Mouse septicaemia, immunity of frog against, 141;
    • phagocytosis in, 283;
    • acquired immunity of rabbit against, 509
  • Mouth. See Buccal cavity
  • Mucous membranes, immunity of the, 407–432;
    • elimination of micro-organisms by the nasal, 410;
    • protective function of the genital, 429
  • Mycoses, pulmonary, 413
    • (see also Aspergillosis)
  • Mygale. See Spiders
  • Myriapods. See Scolopendra
  • Myxomycetes, plasmodia of, 30, 545
  • Naegeli’s theory of immunity, 512
  • Nagana disease, 2, 4, 247, 316
    • (see Trypanosoma)
  • Narcosis. See Opium
  • Nasal mucous membrane, elimination of organisms by, 410
  • Nepenthes, digestive juice of, 355
  • Nerve centres, susceptibility of, to toxins, 564
  • Neuroglia cells, their phagocytic function, 75
  • Neurotoxin, 116
  • Neutral red, reaction of, 13, 83, 181
  • Nuclein as a protective substance, 320;
    • vaccinal against plague, 490
  • Nucleohiston, preventive action of, on diphtheria toxin, 365
  • Nutrition, certain diseases of, probably due to a parasite, 3;
    • extra-buccal, 67, 69
  • Oidium albicans, growth of, in serum of immunised animals, 257
  • Omentum, glands of, 85;
    • bactericidal power of extracts of, 195;
    • phagocytosis of vibrios in, 224
  • Opium, its action on leucocytes, 225, 231, 236, 306, 307;
    • its influence on immunisation by specific serums, 306;
    • resistance of hedgehog to, 337
  • Oryctes nasicornis. See Rhinoceros beetle
  • Osmotic pressure, adaptation of plants to, 37, 39, 566;
    • as cause of bactericidal action of body fluids, 193, 213
  • Ovum in the Graafian follicle, immunity acquired by the, 448
  • Oxalic acid, function of, in plants, 37, 566
  • Oxydases, 96
  • Pancreatic digestion, 60, 63, 65
  • Pancreatic juice, antitoxic power of, 424
  • Pancreatic secretion, its adaptation to kind of food, 64, 65
  • Paralysis, general progressive, and syphilis, 435
  • Paramaecia, 13, 16, 17, 19
  • Parasites in infective diseases, 2, 9
    • (see also Micro-organisms)
  • Pasteur’s theory of exhaustion of nutrient medium, 510–512;
    • anthrax vaccines, 208, 470;
    • modification of Willems’ method against pleuropneumonia, 477;
    • vaccines against rabies, 462, 463–464;
    • and Thuillier’s vaccines against swine erysipelas, 208, 473, 509
  • Pepsin in the urine, 65, 97;
    • in the blood, 66, 563;
    • antitoxic function of, 419;
    • antiseptic action of, 417;
    • chemical composition of, 109
  • Pessimism and fear of disease, 1, 569
  • Peyer’s patches, 61;
    • protective function of, 428
  • Peziza. See Sclerotinia
  • Pfaundler’s reaction, 259
  • Pfeiffer’s phenomenon in cholera vibrio, 165, 192, 212–226, 251, 267, 268, 280, 301–307, 534–536;
    • in spirillum of recurrent fever, 229;
    • in typhoid bacillus, 230, 303, 304;
    • in Bacillus pyocyaneus, 234, 307;
    • different in immunised and in normal fluids, 251;
    • conditions for its manifestation, 252, 253, 295, 534
  • Pfeiffer’s theory of immunity, 534
  • Phagocytes (See also Leucocytes), amoeboid cells with digestive function, 7, 182, 547;
    • in Sponges, 69;
    • in Vertebrata, 73;
    • various categories of, 74–79;
    • of Bipinnaria and Phyllirhoë, 70;
    • chemiotaxis of, 79, 108, 133, 167, 177, 280;
    • the source of the haemolytic ferment, 100;
    • of osseous fishes, 135;
    • of frog, 137;
    • ingest living and virulent bacteria, 142, 177, 179–181, 558, 566;
    • function of, 151, 157, 177, 181, 206, 547, 548, 566;
    • mode of entry of microorganisms into, 177;
    • acid reaction inside, 83, 182;
    • action of opium on, 225, 231;
    • theory of, and side-chain theory compared, 296–299, 538;
    • in defence of animal against poisons, 393–400;
    • in production of antitoxin, 400–402;
    • in the defence of the skin, 407;
    • attempts to reconcile theory of, with humoral theory, 539;
    • history of theory of, 514–525, 539–543;
    • stimulant action of, 532
  • Phagocytic crisis of Bordet, 314;
  • Phagocytosis in osseous fishes, 135;
    • in frogs, 137, 142;
    • in fowl, 144, 282;
    • in dog, 149, 151;
    • in rat, 154, 157;
    • in guinea-pig, 162, 163, 166, 170, 223;
    • in horse, 245, 313;
    • in rabbit, 159, 167, 169, 233, 239, 314;
    • effect of removal of spleen on, 150;
    • agents that prevent, 170–173 (see also Opium);
    • neutralisation of toxins not necessary for, 205, 289;
    • and agglutination, 202, 242, 245;
    • ensures natural immunity, 206;
    • action of opium on, 225, 231, 236, 306, 307;
    • action of rabbit’s serum on, 231;
    • in acquired immunity, 220, 223–226, 245, 280–286, 295, 313;
    • relation to fixatives in acquired immunity, 291, 295;
    • in the immunity conferred by specific serums, 303–317;
    • history of, and of the theory of phagocytes, 514–525, 539–543;
    • its application in surgery, 568
  • Phagolysis, 80, 99, 165;
  • Philocytase, 91, 92
  • Phloridzin, its action on natural immunity, 150
  • Phyllirhoë, two modes of digestion in, 58;
    • resorption by phagocytes of, 70
  • Pig. See also Swine
  • Pig, protection of, against tetanus, 493
  • Pigeon, immunity of, against anthrax, 146;
    • immunity of, against human tuberculosis, 147;
    • immunity of, against influenza bacillus, 130, 554;
    • its blood best culture medium for influenza bacillus, 130, 554;
    • susceptible to swine erysipelas, 476;
    • protective power of serum of, immunised against anthrax, 276, 277, 288;
    • vaccination of, against anthrax, 276, 277
  • Pilocarpin augments production of antitoxin, 380
  • Piroplasma bigeminum, 247, 279
  • Plague, bubonic, rapid immunisation by serum, 312;
    • protective influence of broth against, 321;
    • production of antitoxic serum by, 401;
    • infection by, through the nasal cavity, 409, 411;
    • vaccinations against, 486–492;
    • serum treatment in, 490–492;
    • immunity against, when acquired and duration, 488, 489;
    • statistics on vaccinations against, 488;
    • prophylactic treatment against, 491;
    • Reports of German and English Commissions on, 489
  • Planarians, digestion in, 49, 71, 82
  • Plants, immunity in multicellular, 29–39;
    • cicatrisation of, 34;
    • and osmotic pressure, 37, 39, 566;
    • ravages of Sclerotinia amongst cultivated, 32;
    • action of manures on immunity of cultivated, 36;
    • function of oxalic acid in, 37, 566
  • Plasma, Gengou’s method of preparing, 157, 190
  • Plasmas. See also Body fluids, Serums
  • Plasmas, presence of fixatives in, 103;
    • bactericidal power of, 190, 543
  • Plasmase (fibrin ferment), 95, 197, 550
  • Plasmodia, intracellular digestion in, 30, 545;
    • chemiotaxis of, 30;
    • adaptation of, to poisons, 30
  • Pleuropneumonia, bacterium of, 3, 130, 478, 569;
    • vaccinations against, 477–479;
    • action of serum from animals immunised against, 479;
    • vaccinal methods used by savage races against, 506
  • Pneumococcus, modified growth of, in serums from immunised animals, 256, 262;
    • vaccination against, 262;
    • attenuated by serums from vaccinated animals, 287;
    • agglutination of, 287
  • Pneumo-enteritis of swine, cocco-bacillus of, 259;
    • action of serum of vaccinated rabbits on bacillus of, 260, 266, 287, 532;
    • acquired immunity against, 260, 275, 311, 532
  • Pneumonia, fibrinous, relapses separated by periods of immunity, 434
  • Poisons. See also Toxins
  • Poisons, absorption of, by leucocytes, 393–400
  • Polyphagus euglenae, 12
  • Potato attacked by Bacillus coli, 35
  • Precipitins in the blood serum, 68, 106, 107;
    • use of, in medico-legal investigations, 107, 568;
    • and in the differentiation of various kinds of milk, 107, 568
  • Predisposition or absence of immunity, 7
  • Preventive substances of Bordet (syn. fixatives), 266
  • Profetta, law of, 453
  • Protective or anti-infective property. See also Antitoxic, Antitoxins, Blood, Body fluids, Serums
  • Protective property, origin of, in serums and other fluids, 291–294;
    • differs from agglutinative, 268, 269, 294;
    • of blood and other fluids in convalescents, 437–444
  • Protective action of normal serums, 317–320;
    • of fats against toxins, 387;
    • of leucocytes against poisons, 393–400;
    • of flow of a fluid, 431
  • Protective function of the skin, 404–407;
    • in the respiratory channels, 411–414;
    • of the cornea, 409;
    • of the saliva, 415;
    • of the intestine, 422;
    • of the bile, 424;
    • of the liver, 427;
    • of the lymphoid organs, 428;
    • of the suprarenal capsules, 431;
    • in the urinary organs, 431
  • Protective substance resistant to heat, 268;
    • and so distinguished from bactericidal substance, 268;
    • closely connected with fixative substance, 269, 294, 295, 561
  • Protective vaccinations, 454–504
  • Proteus vulgaris, susceptibility of leucocytes to, 166, 179, 201, 282;
    • eosinophile transformation in, 198;
    • modified growth in certain serums, 259
  • Protozoa, intracellular digestion in the, 13, 30, 49;
    • adaptation of, to saline solutions, 23, 515;
    • and to physical conditions, 26
  • Prussic acid, antidote to, 363
  • Pseudo-diphtheria bacilli, 444
  • Pseudo-eosinophile leucocytes, secretion by, 187, 542
  • Pseudo-immunity or resistance, 320
  • Pus, ferment in, 96
  • Pyrogallic acid, its action on natural immunity, 150
  • Rabbit, immunity of, against anthrax bacillus, 159;
    • against streptococci, 167, 168;
    • against tetanus bacillus, 169;
    • against cholera vibrio, 424;
    • against pleuropneumonia, 569;
    • acquired immunity of, against pyocyanic disease, 232;
    • against swine erysipelas, 236–239, 527;
    • against anthrax, 239, 323;
    • against streptococcus, 243–247, 284–286, 312, 314;
    • against pneumo-enteritis, 260, 266, 275, 311, 532;
    • against pneumococcus, 262;
    • against a staphylococcus, 266;
    • against hog cholera, 290;
    • against mouse septicaemia, 509;
    • phagocytosis in, 159, 167, 169, 233, 239, 314, 569;
    • infection by streptococci in, 283;
    • action of serum of vaccinated, on bacillus of pneumo-enteritis, 287;
    • action of agglutinated pneumococci on, 287;
    • vaccinated against hog cholera susceptible to its toxin, 290;
    • immunised against anthrax by means of the erysipelas coccus, 323;
    • immunised against anthrax by products of Bacillus pyocyaneus, 323;
    • infection by anthrax prevented by Friedländer’s bacillus, 323;
    • brain of, very susceptible to action of tetanus toxin, 383;
    • reaction of, to atropin, 395
  • Rabies, action of anthrax bacillus on, 150;
    • action of normal ox serum on, 365;
    • action of bile on, 425;
    • heredity of immunity against, 446;
    • vaccinations against, 461–466;
    • statistics of vaccinations against, 464–466;
    • in domestic animals, vaccinations against, 466
  • Rat, immunity of, against anthrax bacillus, 152, 526;
    • against diphtheria bacillus, 204;
    • acquired immunity against Trypanosomata, 247–249, 316;
    • against anthrax, 240;
    • natural immunity of, against diphtheria toxin, 204, 339;
    • bactericidal ferment of phagocytes of, 20, 157;
    • phagocytosis in, 154, 157
  • Receptors, 93, 120, 296;
    • over-production of, 121, 296, 562;
    • antitoxic and philotoxic functions of, 120;
    • theory of, see Side-chain theory
  • Recurrent fever. See Spirilla, Spirochaete obermeyeri
  • Recurrent fever, transient acquired immunity against, 434
  • Rennet, 109, 119
  • Reptilia. See Alligator, Turtle, Snake, Lizard
  • Reptilia, natural immunity of, against tetanus toxin, 331–334
  • Resistance to disease, 8–10.
    • See Immunity, Pseudo-immunity
  • Resorption of micro-organisms, 46, 175 (see also Immunity, cellular, Micro-organisms);
    • of the formed elements, 47, 67–105;
    • a true intracellular digestion, 85, 296;
    • of cells in the Invertebrata, 70;
    • of red corpuscles by phagocytes of the Vertebrata, 72, 80 (see also Phagocytes, Phagocytosis);
    • part played by macrophages in (see Macrophages);
    • and digestion closely related, 69, 85;
    • of spermatozoa, 84, 100;
    • of white corpuscles, 84 (see also Leucocytes, Phagocytes);
    • of albuminoid substances, 106–127;
    • of cells and the phenomena in acquired immunity, 296
  • Respiratory channels, protection by the, 411–414;
    • absorption of poisons by the, 414
  • Rhinoceros beetle, natural immunity in larvae of, 132, 209, 326, 329;
    • susceptibility to cholera vibrio, 40, 133
  • Ricin, 344, 360, 446, 449
  • Rinderpest, action of bile on, 425, 466;
    • vaccinations against, 466–468;
    • Koch’s method of vaccination against, 466;
    • Kolle and Turner’s method of “simultaneous vaccinations” against, 467
  • Ring-worm, mechanical factor in, 4
  • Robin (toxalbumin of Robinia pseudacacia), 365;
    • serum of animals vaccinated against, antitoxic, 365;
    • heredity of immunity against, 446
  • Saccharomyces. See Yeasts
  • Saline solution (physiological) as a protective fluid, 320, 365
  • Saliva, microbicidal property of the, 415;
    • antitoxic function of, on snake venom, 417;
    • psychic influence on flow of, 62, 566
  • Saponin, haemolytic action of, 389;
    • and cholesterin, 389;
    • and antisaponic power, 390
  • Saprolegnia. See Fungi
  • Sarcinae as adjuvant organisms, 426
  • Sarcinae, acidophile, 418
  • Sclerotinia, pathogenic action of, 32
  • Scolopendra, acquired immunity in, against anthrax, 209
  • Scorpion, natural immunity of, against tetanus toxin, 326;
    • against its own poison, 327;
    • antivenomous property of blood of, 328;
    • supposed suicide of, 327
  • Scorpion serum, action of antivenomous serum on, 365
  • Scorpion venom, antitoxic action of crayfish blood against, 366
  • Scrofula in immunity against tuberculosis, 436
  • Secretion of bactericidal substance, theory of, 187–191, 533–537, 540, 542
  • Sensibilising substance of Bordet (fixative), 91, 199, 298, 535, 537, 557
  • Sensitiveness of plants to osmotic pressure, 37, 566
  • Septicaemia of goose. See Spirochaete anserina
  • Septicaemia of mouse. See Mouse septicaemia
  • Septic vibrio, 170
  • Serums. See also Blood, Body fluids, Humoral theory, Toxins
  • Serums, haemolysis by, 83, 87–95 (see also Haemolysis);
    • effect of injections of, 68;
    • increasing haemolytic power of, 90;
    • isotoxic, 104;
    • absorption of, 106;
    • antihaemotoxic, 111, 112;
    • haemolytic or haemotoxic, 111, 112;
    • anticoagulating, 190;
    • anticytase, 115, 371;
    • antispermotoxic, 116, 122–126;
    • bactericidal properties of, 184, 190, 191, 192, 193, 206, 211, 226, 233, 238, 241, 243, 244, 260, 298, 554;
    • influence of alkalinity or acidity on bactericidal action of, 196;
    • agglutination of red blood corpuscles by, 258;
    • agglutination of bacteria by, 256–265, 380;
    • protective power of, in the immunised organism, 266–280, 287, 293, 295, 532;
    • differs from bactericidal power, 268;
    • and from agglutinative power, 268;
    • and is not a measure of acquired immunity, 271, 274, 275;
    • protective, may be only feebly antitoxic, 497;
    • modified growth of bacteria in immunised, 256, 259 (see also Agglutination);
    • resistance to heat of protective substance of, 268;
    • fixatives in protective, 269, 438;
    • their origin, 294;
    • protective and fixative substances contrasted, 269;
    • relations of fixative and cytase in bactericidal action of, 298;
    • stimulating action of, 270–274, 301, 308–320, 365;
    • absence of protective power in specific, 270, 276–279;
    • origin of protective power in, 291–294;
    • theory of attenuation of micro-organisms by immune, 286–289;
    • inactive specific, rendered active by addition of normal serum, 215, 268, 298, 302, 317;
    • protective action of heated normal serum, 273, 318;
    • protective action of non-specific, against toxins, 365;
    • from convalescents, protective action of, 437–444;
    • temporary immunity against micro-organisms conferred by specific, 301–317;
    • conferred by normal, 317–320;
    • conferred by fluids other than, 320–322;
    • phagocytosis in the immunity conferred by specific, 303–306;
    • influence of opium on immunisation by specific, 306;
    • antivenomous action of, 334, 338, 358, 360, 361;
    • antitoxic action of non-specific and normal, 365, 380;
    • anti-arsenic, 390;
    • antileucocidic, 359;
    • antidiastatic, 361;
    • testing and standardisation of antitoxic, 376, 476, 496–498
  • Sheath, protective. See Membrane
  • Sheep, natural immunity of, against anthrax, 159, 289;
    • acquired immunity of, against anthrax, 241–3, 289;
    • bactericidal action of blood serum of, 241, 286;
    • protective power of serum of, immunised against anthrax, 276;
    • immunised with blood from dog affected by a haematozoon, 279;
    • vaccination of, against sheep-pox, 460;
    • against rabies, 466;
    • against anthrax, 469;
    • protection against tetanus in, 493;
    • fate of anthrax bacilli in Algerian, 512
  • Sheep-pox (la clavelée), heredity of immunity against, 452;
    • vaccinations against, 460–461
  • Side-chains or receptors, theory of, 120, 381–384, 538, 557, 562–563;
    • compared with theory of phagocytes, 296–299, 538, 558
  • Silver, soluble salts of, absorbed by leucocytes, 400
  • Skin, immunity of the, 403–407;
    • protective function of the, 404–407;
    • phagocytes in the defence of the, 407
  • Small-pox, mortality from, in 18th century, 454;
    • vaccinations against, 454–460;
    • vaccination with calf lymph, 456;
    • with contents of pustule of cow-pox, 455;
    • vaccination statistics, 457–459
  • Snail. See Helix pomatia
  • Snake, natural immunity of, against snake venom, 333
  • Snake venom, natural immunity of snakes against, 333;
    • of hedgehog against, 337;
    • of mongoose against, 339;
    • artificial immunity against, 345, 347;
    • action of antivenomous serum on, 358, 360, 361;
    • of other specific serums on, 365;
    • of cerebral substance on, 386;
    • protective substances against, 387;
    • action of saliva on, 417;
    • action of bile on, 425;
    • vaccination methods of savage races against, 506
  • Spermatozoa, resorption of, 84, 100;
  • Spermotoxin, 101, 116, 125
  • Spiders, natural immunity of, against tetanus toxin, 326
  • Spirilla, natural immunity against, 159;
    • acquired immunity against, 227–230, 434;
    • living in stomach of dog, 177;
    • acidophile, 418
  • Spirochaete anserina, 160
  • Spirochaete obermeyeri, 160;
    • acquired immunity against, 227–230;
    • Pfeiffer’s phenomenon in, 229
  • Spleen, function of, 62, 85;
    • action of extract of, on tetanus toxin, 365;
    • effect of removal of, 150, 293;
    • as source of fixative substance, 295, 537
  • Spleen and other haematopoietic organs as source of protective substance, 292–294;
    • as source of agglutinins, 264;
    • are phagocytic organs, 85, 150, 292
  • Sponges, digestion of, 69, 517
  • Staining reactions of cells and micro-organisms, 13, 77, 83, 181, 183, 198, 213
  • Standardisation of antidiphtheria serums, 376, 496–498;
    • Ehrlich’s method, 496;
    • Pasteur Institute method, 496–497
  • Staphylococcus, acquired immunity against, 266, 532;
    • protective action of normal serum against, 319
  • Staphylococcus pyogenes in vagina, 430
  • Stellate cells of Kupffer, 75
  • Stimulant action. See also Body fluids, Protective
  • Stimulant action of serums, 270–274, 301, 308–320, 365;
    • of phagocytes, 532;
    • of normal fluids of the body, 559
  • Stimulins and their action in serums, 270–274
  • Stöhr’s phenomenon, 429
  • Stomach, acidophile microbian flora of, 418
  • Streptococci, protective sheath formed by, 22;
    • immunity against, 165, 179, 282, 284–286;
    • phagocytosis in immunity against, 245, 313;
    • acquired immunity against, 243–247, 313;
    • agglutination by serum of, 244, 245;
    • reaction of animal organism against, 245–247;
    • antitoxin against, 205;
    • and phagocytosis, 283;
    • action of specific serums on, 287, 288, 312;
    • protective action of various fluids against, 320, 321
  • Streptococcic serum, action of, on leucocidin, 359
  • Sturin, bactericidal action of, 183
  • Suprarenal capsules, protective function of, 431
  • Susceptibility. See also Chemiotaxis, Hypersusceptibility, Irritability, Sensitiveness
  • Susceptibility of immunised animals to the specific toxin, 289;
    • of frogs to tetanus toxin, 330;
    • diminution of, in immunised animals, 374–376;
    • in immunity, the part played by, 565;
    • cellular, a general property of living beings, 565–566
  • Swine. See Pig, Pneumo-enteritis
  • Swine erysipelas, acquired immunity against, 236–239, 254, 283, 527;
    • agglutination of bacilli of, 262;
    • specific serum of, will not prevent infection, 270;
    • phagocytosis in, 283;
    • action of immune serums on bacillus of, 288, 289;
    • protective action of specific serum against, 307;
    • method of testing strength of serums against, 476;
    • vaccinations against, 473–477;
    • Pasteur’s method, 473;
    • Lorenz’s method, 475;
    • “serum-vaccinations” method, 475;
    • vaccines against, 208, 473, 509
  • Swine plague, 259, 260
  • Synapta, 518
  • Syphilis, immunity in, 435;
    • and general progressive paralysis, 435;
    • law of Profetta in immunity against, 453;
    • law of Baumès-Colles in, 436;
    • transmission of, 452
  • Tears, microbicidal function of the, 408
  • Testing of serums. See Standardisation
  • Tetanolysin of Ehrlich, 349
  • Tetanospasmin, 362
  • Tetanus, immunisation against, 344, 347, 492–495;
    • cerebral, in rabbit, 383, 391;
    • difference between antitoxic action of living brain and that of cerebral emulsion on, 383;
    • in fowl, 384;
    • no antitetanic power in serum of convalescents, 443;
    • vaccinations against, 492–495;
    • vaccines against, 493;
    • protective serum treatment against, 493–495
  • Tetanus antitoxin, hypothesis of nervous origin of, 381–385;
    • nature of, 355;
    • mode of action on toxin, 357, 381;
    • of nerve centres locally restricted in its action, 382
  • Tetanus bacillus, natural immunity against, 169, 204
  • Tetanus toxin, natural immunity of spiders and scorpions against, 326;
    • of larvae of Oryctes and of cricket against, 329;
    • of frog against, 330;
    • of reptiles against, 331–334;
    • of fowl against, 335;
    • of hibernating animals against, 339;
    • attenuation of, 344;
    • localisation of, in vascular organs, 336;
    • brain of rabbit very susceptible to action of, 383;
    • fixation of, by substance of nerve centres, 382;
    • by certain parts of brain and cord, 386, 391;
    • by other cells, 391, 392;
    • action of emulsions of frog’s brain on, 386;
    • fixation of, by carmine, 388, 394;
    • absorption of, by leucocytes, 393–395;
    • action of extract of spleen on, 365;
    • toxone (tetanolysin) of, 349, 362;
    • local reaction to, in horse, 352;
    • heredity of immunity against, 446, 448, 450
  • Texas fever, acquired immunity of Bovidae against, 247, 279;
    • attenuation of parasite of, in the tick, 247;
    • haematozoon in dog closely allied to that of, 279
  • Thetys, 517
  • Thymus gland, immunising power of, 293
  • Tick, attenuation of parasite of Texas fever in, 247
  • Tonsils, protective function of, 428
  • Torulae as adjuvant organisms, 426
  • Toxins, immunity against, 10;
    • immunity of unicellular organisms against, 19;
    • adaptation of bacteria to, 21–27;
    • of yeasts to, 20, 26;
    • of plasmodia to, 30;
    • action of, on Infusoria, 19, 326;
    • composition of, 120;
    • neutralisation of, not necessary for phagocytosis, 205, 289;
    • immunity against micro-organism not same as against toxin, 251, 290;
    • protective fixation of, by nerve elements and other cells, 386–400;
    • methods of immunisation by modified and unmodified, 345–347 (see Immunisation);
    • local reaction in immunisation against, 352;
    • action of normal serums on, 365;
    • of non-specific serums on, 365;
    • protective action of fats against, 387;
    • leucocytic reaction against, 393–400;
    • absorption of, by the conjunctiva, 409;
    • by the respiratory channels, 414;
    • destruction of, by the intestinal organisms, 427;
    • attenuation of, 344;
    • natural immunity against, 325–341;
    • artificial immunity against, 342–402;
    • against bacterial, 343;
    • against vegetable, 344, 365;
    • heredity of immunity in phanerogamic, 446, 449;
    • susceptibility of nerve centres to, 564
  • Toxoids, 349 (see also Toxophore);
    • immunisation by, 350
  • Toxones, 349, 362;
    • method of immunisation by, 349
  • Toxophore atomic group in toxin (= toxoid), 120, 350, 384
  • Trichinae, mechanical action of, 3
  • Tristeza (syn. Texas fever), 247
  • Tropidonotus. See Snake
  • Trypanosoma, 4, 129, 147;
  • Trypanosomata, fate of, in refractory animal, 173;
    • acquired immunity against, 247–249, 316;
    • and agglutinative power, 278
  • Trypsin, antitoxic power of, 424
  • Tsetse fly, 4, 9, 129, 247
  • Tubercle bacillus, formation of sheath by, 22, 183
  • Tuberculin as a protective substance against cholera vibrio, 320
  • Tuberculosis, mechanical etiological factors in, 4
  • Tuberculosis, bacillus of, 22, 42, 143;
    • avian, 41, 148, 149, 182;
    • human, immunity of pigeon against, 147;
    • acquired immunity in, 436;
    • after scrofula, 436;
    • Koch’s phenomenon in, 437
  • Tumours, malignant, probability of discovery of parasite of, 3;
    • use of erysipelas streptococcus in, 434
  • Turtle, natural immunity of, against tetanus toxin, 332, 386
  • Typhoid, protective power of serum of convalescents from, 437–440;
    • its agglutinative power, 439;
    • serum-diagnosis of, 256, 257, 261, 439;
    • immunity against, not acquired by suckling, 450;
    • vaccinations against, 479, 481–486;
    • Wright’s vaccine against, 482;
    • bactericidal power of serum from persons immunised against, 483;
    • statistics of vaccinations against, 483–485
  • Typhoid bacillus, 23, 143, 191, 198, 203;
    • acquired immunity against, 230;
    • attenuated Pfeiffer’s phenomenon in, 230, 303, 304;
    • agglutination of, 260, 261, 380, 439;
    • resistance to agglutinated, 263;
    • protective action of serums against, 272–274, 293, 317, 319;
    • origin of protective substance against, 292;
    • of agglutinative property against, 294;
    • protective action of various fluids against, 320;
    • passes uninjured through stomach, 418;
    • transmission by suckling, of agglutinative power against, 450
  • Typhoid infection, experimental, in laboratory animals, 230, 267;
    • influence of anticytase serum on, 371;
    • uncertainty of, by ingestion, 423
  • Typhoid septicaemia, experimental, heredity of immunity against, 447
  • Tyrosin, protective action of, 387
  • Unicellular organisms, immunity in, 11–28;
    • infective diseases of, 12;
    • irritability of, 27;
    • adaptation of, to saline solutions, 23, 515
  • Unit, Ehrlich’s immunising, 373, 496
  • Urinary ferments, 66
  • Urinary organs, protective function in, 431
  • Urine as a protective fluid, 320, 431;
    • pepsin in the, 65;
    • amylase in the, 65
  • Vaccination. See also Immunisation
  • Vaccinations, protective, 208, 241, 267, 454–504, 507;
    • with attenuated micro-organisms, 509
  • Vaccine against fowl cholera, 208
  • Vaccines against anthrax, 208, 470, 509;
    • against swine erysipelas, 208, 473, 509;
    • against rabies, 208, 462, 463–464;
    • against symptomatic anthrax, 471;
    • against small-pox, 455–457, 507;
    • against pleuropneumonia, 477;
    • against cholera, 481;
    • against plague, 487, 489, 490;
    • against tetanus, 493
  • Vaccinia, supposed micro-organism of, 455–456
  • Vagina, autopurification of, 429
  • Variolisation, early use of, 455, 507
  • Venom. See Snake venom
  • Ver blanc, syn. cockchafer larva
  • Vibrio. See also Cholera vibrio, Massowah vibrio, Septic vibrio
  • Vibrios, acquired immunity against, 211–227;
    • phagocytosis in immunity against, 220, 223–226;
    • granular transformation of, 164, 165, 192, 212–226 (see Pfeiffer’s phenomenon);
    • bacteriolysis (agglutination) of, 256;
    • susceptibility of animals vaccinated against, to the toxins, 290
  • Vibrio metchnikovi, acquired immunity against, 211, 226, 527, 531;
    • modified growth of, in serums from immunised animals, 156, 262;
    • action of, grown in serum of vaccinated animals, 287;
    • perishes in intestine of dog, 422;
    • action of microcytase on, in hypervaccinated guinea-pigs, 553
  • Viper. See Snake, Snake venom
  • Viruses, attenuated, 208, 508;
    • vaccination with, whose nature is as yet unknown. See Small-pox, Sheep-pox, Rabies, Rinderpest
  • Vitellus of egg of immunised fowl, tetanus antitoxin present in, 356;
    • immunity conferred by, 449
  • Warlomont’s calf lymph vaccine, 456
  • Weber-Fechner, law of, 27, 38, 566
  • Willem’s method of vaccination against pleuropneumonia, 477;
    • Pasteur’s modification of, 477
  • Wright’s method of vaccination against typhoid, 482;
    • method of testing bactericidal power of body fluids, 483
  • Yeast-cells, adaptation of, to poisons, 20, 26;
    • to milk-sugar, 26;
    • destruction of injected, by phagocytes, 172;
    • Curtis’s pathogenic, 172;
    • endotrypsin of, 197;
    • autodigestion in, 197;
    • soluble ferments of, 253
  • Yeasts, diseases due to, 2
  • Yolk. See Vitellus
  • Zymase, 197, 550